Latest Director Participation News

Page 11 of 19
Pure Hydrogen Corporation has raised A$1 million through a share placement with attaching options, aiming to accelerate its clean energy projects across Australia and the US.
Maxwell Dee
Maxwell Dee
28 Aug 2025
Cambium Bio has updated its placement, raising A$2.17 million to fund late-stage clinical trials for its lead ophthalmology product, Elate Ocular®. The capital raise reflects strong investor interest and strategic backing.
Ada Torres
Ada Torres
27 Aug 2025
MRG Metals has successfully raised over $500,000 through an entitlement offer, issuing new options to fund exploration in Mozambique while directors fully subscribed and plan further participation.
Maxwell Dee
Maxwell Dee
27 Aug 2025
Felix Group Holdings Ltd has launched a capped $1 million Share Purchase Plan (SPP) offering eligible shareholders a discounted entry to support its strategic acquisition of Nexvia Pty Ltd and fuel growth initiatives. This retail-focused SPP complements a larger institutional placement as Felix aims to expand its enterprise software footprint.
Sophie Babbage
Sophie Babbage
26 Aug 2025
EPX Limited has successfully raised $2 million through a private placement, positioning itself to expand sales, explore acquisitions, and enhance its energy efficiency technology platform.
Sophie Babbage
Sophie Babbage
21 Aug 2025
Melbana Energy has successfully raised $7 million through a discounted share placement with attaching and bonus options, aiming to finance drilling at its Amistad-2 well and support general corporate needs.
Maxwell Dee
Maxwell Dee
21 Aug 2025
Beonic Ltd has raised a total of $4.18 million through convertible notes to fund product innovation, repay debt, and advance its North African Airport Project. Major shareholders and directors are backing the raise, subject to shareholder approval.
Sophie Babbage
Sophie Babbage
21 Aug 2025
Xamble Group has launched a partially underwritten renounceable rights issue to raise $1.35 million, aiming to accelerate platform adoption and technology innovation while offering flexible participation for investors.
Sophie Babbage
Sophie Babbage
20 Aug 2025
Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.
Ada Torres
Ada Torres
18 Aug 2025
Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $1.45 million, aimed at funding early development and exploration activities in Tanzania. The offer includes free attaching options and is partially underwritten, with significant implications for shareholder dilution and company control.
Maxwell Dee
Maxwell Dee
14 Aug 2025
Paterson Resources has raised A$2 million through a discounted placement and entitlement offer, fully funding an 8,500m drilling program and key project studies at its Grace Project.
Maxwell Dee
Maxwell Dee
13 Aug 2025
Magnetite Mines Limited has announced a renounceable rights issue to raise up to $2.65 million, aiming to fund critical development milestones for its Razorback Iron Ore Project and secure strategic partnerships for DFS funding.
Maxwell Dee
Maxwell Dee
8 Aug 2025